Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
GSK plc - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
GSK
New York
2830
www.gsk.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for GSK plc
GSK (LSE:GSK) Wins FDA Approval For Utebzi As Momelotinib Gains Orphan Tag
- Jun 26th, 2026 8:07 am
FDA Expands IONS' Tryngolza Label to Treat Severe Hypertriglyceridemia
- Jun 25th, 2026 11:29 am
Is GSK plc (GSK) Expanding Its Anti-Infectives Leadership With New FDA-Approved Therapy?
- Jun 24th, 2026 7:27 am
Top Analyst Reports for Micron Technology, Coca-Cola & Arista Networks
- Jun 23rd, 2026 2:29 pm
3 Top Dividend Stocks to Maximize Your Retirement Income
- Jun 23rd, 2026 7:10 am
GSK, Spero Win FDA Nod For First-Ever Oral Carbapenem Antibiotic For Complicated UTIs
- Jun 21st, 2026 8:31 am
Biogen to Strengthen Immunology Pipeline With $1B RayThera Buyout
- Jun 18th, 2026 7:51 am
GSK's Utebzi Wins FDA Nod for Complicated Urinary Tract Infections
- Jun 18th, 2026 6:57 am
Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
- Jun 17th, 2026 2:21 pm
The Zacks Analyst Blog Highlights Gilead Sciences, Merck and GSK
- Jun 17th, 2026 1:41 am
[Latest] Global GLP-1 Receptor Agonist Market Size/Share Worth USD 95.3 Billion by 2035 at a 12.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
- Jun 16th, 2026 4:30 pm
FDA Accepts Gilead's Filing for Weekly Oral Yeztugo for HIV Prevention
- Jun 16th, 2026 12:17 pm
Sector Update: Healthcare Stocks Advance in Afternoon Trading
- Jun 16th, 2026 11:29 am
MarketBeat Week in Review – 06/08 - 06/12
- Jun 13th, 2026 5:00 am
GSK Engitix Liver Fibrosis Pact Adds Early Stage Upside For Valuation
- Jun 12th, 2026 7:10 pm
GSK's Momelotinib Gets Orphan Tag for Rare Hemato-Inflammatory Disorder
- Jun 12th, 2026 7:52 am
Pharma and Biotech M&A Boom Accelerates as Companies Expand Pipelines
- Jun 11th, 2026 11:24 am
Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion
- Jun 11th, 2026 10:25 am
Can Gilead Sciences HIV Franchise Drive Long-Term Growth?
- Jun 10th, 2026 12:12 pm
Nike downgraded, Oscar Health upgraded: Wall Street's top analyst calls
- Jun 10th, 2026 7:42 am
Scroll